Timing of Umbilical Cord Blood Derived Mesenchymal Stem Cells Transplantation Determines Therapeutic Efficacy in the Neonatal Hyperoxic Lung Injury

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Chang, Yun Sil ^a,b   Choi, Soo Jin ^c   Ahn, So Yoon ^a   Sung, Dong Kyung ^b   Sung, Se In ^a   Yoo, Hye Soo ^a   Oh, Won Il ^c   Park, Won Soon ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c MEDIPOST Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHEMOKINE; COLLAGEN; CXCL7 CHEMOKINE; ED1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; L SELECTIN; MYELOPEROXIDASE; PROTEIN P47; RANTES; SCATTER FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALVEOLARIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH RETARDATION; HUMAN; HUMAN CELL; HYPEROXIA; LONG TERM EXPOSURE; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG DEVELOPMENT; LUNG INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; NEWBORN; NEWBORN DISEASE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PERINATAL PERIOD; PROCESS OPTIMIZATION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; RAT; THERAPY DELAY; TIME; UMBILICAL CORD BLOOD; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CELL MEMBRANE; COLLAGEN; CYTOKINES; CYTOSOL; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPEROXIA; LUNG INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NADPH OXIDASE; PEROXIDASE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84872673125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052419     Document Type: Article

References (36)

1. Saigal S, Doyle LW, (2008) An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371: 261-269.
2. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, et al. (1987) Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79: 26-30.
3. Bregman J, Farrell EE, (1992) Neurodevelopmental outcome in infants with bronchopulmonary dysplasia. Clin Perinatol 19: 673-694.
4. Fahy JV, (2009) Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc 6: 256-259.
5. Choo-Wing R, Nedrelow JH, Homer RJ, Elias JA, Bhandari V, (2007) Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 293: L142-150.
6. Warner BB, Stuart LA, Papes RA, Wispe JR, (1998) Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 275: L110-117.
7. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, et al. (2009) Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 18: 869-886.
8. Chang YS, Choi SJ, Sung DK, Kim SY, Oh W, et al. (2011) Intratracheal transplantation of human umbilical cord blood derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant.
9. Jang YK, Jung DH, Jung MH, Kim DH, Yoo KH, et al. (2006) Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 85: 212-225.
10. Yang SE, Ha CW, Jung M, Jin HJ, Lee M, et al. (2004) Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 6: 476-486.
11. Boiani M, Scholer HR, (2005) Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6: 872-884.
12. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC, (2007) SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109: 1743-1751.
13. Lee JK, Lee MK, Jin HJ, Kim DS, Yang YS, et al. (2007) Efficient intracytoplasmic labeling of human umbilical cord blood mesenchymal stromal cells with ferumoxides. Cell Transplant 16: 849-857.
14. Thurlbeck WM, (1982) Postnatal human lung growth. Thorax 37: 564-571.
15. Cho SJ, George CL, Snyder JM, Acarregui MJ, (2005) Retinoic acid and erythropoietin maintain alveolar development in mice treated with an angiogenesis inhibitor. Am J Respir Cell Mol Biol 33: 622-628.
16. Snyder JM, Jenkins-Moore M, Jackson SK, Goss KL, Dai HH, et al. (2005) Alveolarization in retinoic acid receptor-beta-deficient mice. Pediatr Res 57: 384-391.
17. Babior BM, (1999) NADPH oxidase: an update. Blood 93: 1464-1476.
18. Cross AR, Segal AW, (2004) The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochim Biophys Acta 1657: 1-22.
19. Gray KD, Simovic MO, Chapman WC, Blackwell TS, Christman JW, et al. (2003) Endotoxin potentiates lung injury in cerulein-induced pancreatitis. Am J Surg 186: 526-530.
20. Robinson JM, Badwey JA, (1995) The NADPH oxidase complex of phagocytic leukocytes: a biochemical and cytochemical view. Histochem Cell Biol 103: 163-180.
21. Hohler B, Holzapfel B, Kummer W, (2000) NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochem Cell Biol 114: 29-37.
22. Li JM, Shah AM, (2002) Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277: 19952-19960.
23. Coalson JJ, (2003) Pathology of new bronchopulmonary dysplasia. Semin Neonatol 8: 73-81.
24. Jobe AJ, (1999) The new BPD: an arrest of lung development. Pediatr Res 46: 641-643.
25. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, et al. (2005) Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 289: L529-535.
26. McGrath-Morrow SA, Stahl J, (2001) Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol 25: 150-155.
27. Reinecke H, Murry CE, (2002) Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J Mol Cell Cardiol 34: 251-253.
28. Togel F, Hu Z, Weiss K, Isaac J, Lange C, et al. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289: F31-42.
29. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, et al. (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20: 661-669.
30. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, et al. (2009) Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180: 1122-1130.
31. Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, et al. (2007) Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 204: 3257-3269.
32. Saugstad OD, (2003) Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 8: 39-49.
33. Bastian NR, Hibbs JB Jr, (1994) Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr Opin Immunol 6: 131-139.
34. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, et al. (2009) Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 175: 303-313.
35. Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, et al. (2009) Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 120: S247-254.
36. Kokaia Z, Martino G, Schwartz M, Lindvall O, (2012) Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci 15: 1078-1087.